Decibel Therapeutics, Inc.
(NASDAQ GS: DBTX)
Rigrodsky Law, P.A. is investigating Decibel Therapeutics, Inc. (“Decibel”) regarding possible breaches of fiduciary duties and other violations of law related to Decibel’s agreement to be acquired by Regeneron Pharmaceuticals, Inc. Under the terms of the agreement, Decibel shareholders will receive $4.00 per share in cash.